Towards the next phase: evaluation of serological assays for diagnostics and exposure assessment
Corine H. GeurtsvanKessel, View ORCID ProfileNisreen M.A. Okba, Zsofia Igloi, Carmen W.E. Embregts, Brigitta M. Laksono, Lonneke Leijten, Janette Rahamat-Langendoen, Johannes P.C. van den Akker, Jeroen J.A. van Kampen, Annemiek A. van der Eijk, Rob S. van Binnendijk, Bart Haagmans, Marion Koopmans
doi: https://doi.org/10.1101/2020.04.23.20077156
Corine H. GeurtsvanKessel
1Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands
Nisreen M.A. Okba
1Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands
Zsofia Igloi
1Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands
Carmen W.E. Embregts
1Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands
Brigitta M. Laksono
1Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands
Lonneke Leijten
1Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands
Janette Rahamat-Langendoen
2Department of Medical Microbiology, Radboud University Medical Centre, Nijmegen, The Netherlands
Johannes P.C. van den Akker
3Department of Intensive Care, Erasmus MC, Rotterdam, the Netherlands
Jeroen J.A. van Kampen
1Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands
Annemiek A. van der Eijk
1Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands
Rob S. van Binnendijk
4Center for Infectious Disease Control, RIVM, Bilthoven, The Netherlands
Bart Haagmans
1Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands
Marion Koopmans
1Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands
Posted April 29, 2020.
Towards the next phase: evaluation of serological assays for diagnostics and exposure assessment
Corine H. GeurtsvanKessel, Nisreen M.A. Okba, Zsofia Igloi, Carmen W.E. Embregts, Brigitta M. Laksono, Lonneke Leijten, Janette Rahamat-Langendoen, Johannes P.C. van den Akker, Jeroen J.A. van Kampen, Annemiek A. van der Eijk, Rob S. van Binnendijk, Bart Haagmans, Marion Koopmans
medRxiv 2020.04.23.20077156; doi: https://doi.org/10.1101/2020.04.23.20077156
Towards the next phase: evaluation of serological assays for diagnostics and exposure assessment
Corine H. GeurtsvanKessel, Nisreen M.A. Okba, Zsofia Igloi, Carmen W.E. Embregts, Brigitta M. Laksono, Lonneke Leijten, Janette Rahamat-Langendoen, Johannes P.C. van den Akker, Jeroen J.A. van Kampen, Annemiek A. van der Eijk, Rob S. van Binnendijk, Bart Haagmans, Marion Koopmans
medRxiv 2020.04.23.20077156; doi: https://doi.org/10.1101/2020.04.23.20077156
Subject Area
Subject Areas
- Addiction Medicine (380)
- Allergy and Immunology (697)
- Anesthesia (187)
- Cardiovascular Medicine (2817)
- Dermatology (241)
- Emergency Medicine (425)
- Epidemiology (12511)
- Forensic Medicine (10)
- Gastroenterology (798)
- Genetic and Genomic Medicine (4380)
- Geriatric Medicine (398)
- Health Economics (711)
- Health Informatics (2824)
- Health Policy (1042)
- Hematology (372)
- HIV/AIDS (892)
- Medical Education (412)
- Medical Ethics (113)
- Nephrology (460)
- Neurology (4144)
- Nursing (219)
- Nutrition (614)
- Oncology (2182)
- Ophthalmology (620)
- Orthopedics (253)
- Otolaryngology (316)
- Pain Medicine (262)
- Palliative Medicine (81)
- Pathology (483)
- Pediatrics (1166)
- Primary Care Research (481)
- Public and Global Health (6728)
- Radiology and Imaging (1479)
- Respiratory Medicine (895)
- Rheumatology (429)
- Sports Medicine (359)
- Surgery (468)
- Toxicology (57)
- Transplantation (198)
- Urology (173)